DNA from Molluscum contagiosum virus (MCV) isolates was analysed by restriction endonuclease cleavage, revealing two virus subtypes. Physical maps of cleavage sites for BamHI, Clal and HindIII were constructed, and found to differ extensively between the two subtypes. MCV DNA was similar to Orthopoxvirus DNA with respect to size, terminal cross-linking and the presence of inverted terminal repetitions, but did not hybridize with vaccinia virus DNA. The genomes of the two MCV subtypes crosshybridized and were colinear except for two small regions. There was sequence homology between DNA from corresponding map regions of the MCV subtypes but, in contrast to Orthopoxvirus DNA, no conservation of restriction sites. A synthetic oligonucleotide probe representing a conserved domain of epidermal growth factor, c~-transforming growth factor and the vaccinia growth factor identified equivalent regions of both MCV genomes as having the potential to encode this domain. This locus is similar to the position of the vaccinia growth factor gene in vaccinia virus DNA. Thus MCV may induce epidermal cell proliferation and tumourigenesis by expression of an epidermal growth factor-like polypeptide.
INTRODUCTION
Molluscum contagiosum virus (MCV) is an unclassified poxvirus of man which induces benign skin tumours. Transmission is mechanical and, in adults, may be venereal. The skin lesion consists of a localized mass of hypertrophied and hyperplastic epidermis extending down into the underlying dermis and projecting above the surface as a papule. The rate of cell division in the basal layer is several times that of normal skin. The lower cells of the stratum spinosum contain characteristic cytoplasmic inclusion bodies resulting from virus replication, which enlarge as the infected cells migrate through the stratum granulosum towards the surface. These molluscum bodies are trapped in the horny layer by a fibrous network which dissolves in the centre of the lesion forming a central core composed primarily of virus. The disease is selflimiting but lesions may be curetted or the virus-rich core collected. Attempts to propagate virus in vitro have not been successful (Postlethwaite, 1970) . Parr et al. (1977) studied the MCV genome by electron microscopy and showed by partial denaturation that it is a terminally cross-linked molecule of about 180 kb. They also demonstrated three different BamHI cleavage patterns of DNA from MCV isolates. Dural et aL (1986) have reported two viral subtypes on the basis of different cleavage patterns.
MCV is one of several tumourigenic poxviruses. Others are Shope rabbit fibroma virus and Yaba monkey tumour virus which induce fibromas and histiocytomas respectively. Induction of epidermal cell proliferation by poxviruses is of interest following recent studies demonstrating that a vaccinia virus Mr 19 000 (19K) polypeptide is structurally and functionally homologous to epidermal growth factor (EGF) and to c~-transforming growth factor (~-TGF) Blomquist et al., 1984; Reisner, 1985 ; Stroobant et al., 1985; Twardzik et al., 1985; King et 0000-7486 © 1987 SGM al., 1986 . However, these growth factor genes do not possess homology at the DNA level (Venkatesan et al., 1982; Lee et al., 1985; Derynck et al., 1984; Scott et al., 1983; Gray et al., 1983) . The function of the vaccinia growth factor (VGF) in the replication of vaccinia virus, which grows lytically, is unknown.
Here we report restriction endonuclease mapping of the MCV genome and demonstrate two viral subtypes, designated MCV I and MCV II, which have different restriction maps. We report also that MCV DNA, which does not show homology to Orthopoxvirus DNA, contains a sequence capable of encoding a polypeptide homologous to a conserved region of EGF, ct-TGF and VGF, and propose that this is involved in cell proliferation and tumour formation.
METHODS
Virus purification. Lesions were obtained from a variety of sites including limbs, trunk, head and external genitalia. Curetted lesions or cores were chopped finely and homogenized in 1 mM-Tris HC1 pH 9.0. The homogenate was layered on 10% dextran T10 above a column of 36% sucrose in the same buffer. Virus was pelleted by centrifugation at 16000 g for 1 h. The virus pellet was purified further by a second centrifugation as above.
Extraction and cleavage ofDNA. Purified virus, cores or, in some cases, homogenized lesions, were lysed in 100 mM-Tris-HCl pH 7-5, 10 mM-EDTA, 70 mM-2-mercaptoethanol, 0'1% SDS, 1% sodium n-lauryl sarcosinate, 0.5 mg/ml proteinase K (Boehringer) and incubated at 42 to 55 °C until clear. Digests were deproteinized by extraction with phenol, phenol :chloroform :amyl alcohol (24:24 : 1), and chloroform :amyl alcohol (24: 1). DNA was precipitated in ethanol and cleaved according to standard methods (Maniatis et al., 1982) using restriction endonucleases from various commercial suppliers. Fragment molarities were estimated by scanning densitometry.
DNA blotting and hybridization. Restriction fragments were separated by agarose slab gel electrophoresis and transferred to nitrocellulose using standard methods (Maniatis et al., 1982) . Hybridization probes were prepared by isolation of DNA restriction fragments from low-gelling temperature agarose and labelled with [ct-32p]dCTP (3000 Ci/mmol) using random oligonucleotide primer extension (Feinberg & Vogelstein, 1984) . Probes were separated from unincorporated nucleotides by Sephadex G-50 chromatography. Typical specific activities were 108 to 109 d.p.m.Atg.
Prehybridization (for 16 h) and hybridization (for 20 h) was at 65 °C in 6 x SSC, 5 × Denhardt's solution, 0.5 % SDS, 100 pg/ml denatured sonicated salmon sperm DNA (1 × SSC is 150 mM-NaCI, 15 raM-sodium citrate pH 7.0 and 1 × Denhardt's solution is 0.02% Ficoll 70, 0.02% polyvinylpyrrolidone, 0.02% bovine serum albumin). Probes were denatured by heating in 0.2 M-NaOH and neutralized by addition of an equivalent of HC1 in the presence of 100 mM-Tris-HC1 pH7.5. Following hybridization, filters were washed at 65 °C for 20 min periods in successively lower salt concentrations, finishing with 0.1 x SSC, 0.1% SDS. Autoradiography was at -70 °C using pre-flashed Kod~ik X-Omat XAR-5 or Fuji Rxl00 film.
Oligonucleotide synthesis and purification. Oligonucleotides were synthesized by the phosphoramidite method using a Pharmacia Gene Assembler. The sequences and their method of selection are described below. After deprotection, oligonucleotides were purified by Sephadex G-25 chromatography followed by polyacrylamide gel electrophoresis. The excised gel slice was soaked overnight in 10 mM-Tris-HC1 pH 8.0, 1 mM-EDTA to elute the oligonucleotide, which was recovered by Sephadex G-25 chromatography, dried down and dissolved in 10 mMTris-HCl pH 8.0, 1 mM-EDTA at 50 ng/ptl.
Oligonucleotide labelling and hybridization. Oligonucleotides were 5' end-labelled using [7-32p] ATP (3000 Ci/mmol) and T4 polynucleotide kinase (Maniatis et al., 1982) and purified by Sephadex G-25 chromatography.
Typical specific activities were 1 x 106 to 5 × 106 d.p.m./pmol.
Virus DNA was cleaved, separated and transferred to nitrocellulose as described above. Prehybridization (for 4 h) and hybridization (for 16 h) was at 30 °C in 6 x SSC, 5 × Denhardt's solution, 100 ~tg/ml denatured Escherichia coli tRNA. Labelled oligonucleotide was added to a concentration of 4 pmol/ml. Following hybridization, filters were washed in 6 x SSC, 0.1 ~ SDS for 2 h at 30 °C, and subsequently as indicated in Fig. 6 . Autoradiography was at -70 °C using preflashed Kodak X-Omat XAR-5 film.
RESULTS

Preliminary characterization of MCV genome
Molluscum contagiosum lesions were obtained either as curetted tumours or as isolated cores. In some cases, where several lesions were clustered at the same site and might reasonably be assumed to have resulted from the same infection, lesions were pooled. No evidence of mixed infection has been obtained. 67~o formamide was used to identify these (Fig. 2) . For MCV I, HindlII and Sinai generated single, 2-molar rapidly renaturing fragments, whereas BamHI, ClaI, PstI and XhoI generated two such fragments. This result indicates that MCV DNA possesses a terminal inverted repeat, another feature of Orthopoxvirus DNA (Wittek et al., 1978; Mackett & Archard, 1979) . For MCV I the largest 2-molar terminal fragment and the smallest 1-molar terminal fragment observed were 3.9 kb (SmaI) and 5.4 kb (PstI) respectively, placing lower and upper limits on the size of the repeat, The size of terminal fragments generated by a particular endonuclease varied in DNA from different isolates (see below).
Restriction mapping and cross-hybridization
We have mapped the restriction sites for BamHI, ClaI and HindllI in both MCV I and MCV II DNA. Fragments generated by cleavage with one of these enzymes were isolated from gels, labelled and hybridized to Southern blots of homologous and heterologous digests of the same DNA. Fragments BamHI/A to N; ClaI/C, D, G and H; HindlII/A to O were used as probes to map MCV I DNA. Those for MCV II were BamHI/D to I; CIaI/A to H. These hybridizations confirmed the presence of terminal repetitions (by cross-hybridization) and generated linkage groups which allowed us to construct restriction maps for these enzymes (Fig. 3) . Some mapping data for PstI, Sinai and XhoI were also obtained for MCV I DNA (data not shown).
The maps for MCV I and MCV II DNA show no conservation of restriction sites. However, the genomes of the two subtypes are highly homologous, as a total MCV I probe cross-hybridized to all MCV II BamHI, ClaI and HindlII fragments; a total MCV II probe cross-hybridized to all MCV I BamHI, ClaI and HindlII fragments, with the exception of BamHI/K and O (Fig. 4) . Total probes were generated by digesting genomic DNA with BamHI followed by denaturation and random oligonucleotide primer extension (Feinberg & Vogelstein, 1984) . These hybrids were stable under stringent washing conditions (65 °C in 0.1 x SSC, 0.1 SDS). We have investigated this cross-hybridization further by probing MCV I DNA digests with MCV II fragments CIaI/A to H and by probing MCV II DNA digests with MCV I fragments BamHI/A to N. This allowed us to orientate the maps of MCV I and MCV II with respect to each other (Fig. 3) and demonstrates colinearity of the sequences, with the exceptions noted above. SmaI generated a single 2-molar terminal fragment, whereas PstI and XhoI each generated two different termini. The high molecular weight smearing in some SmaI and XhoI digests is due to residual cell DNA which was not cleaved due to methylation of the CpG dinucleotide in the recognition sequences of these enzymes. Figures refer to DNA size markers (kb) generated by HindIII cleavage of 2 DNA.
Oligonucleotide design and hybridizations
We wished to investigate the possibility that the M C V genome encodes a growth factor analogous to E G F . An oligonucleotide (17-mer) designed to hybridize to D N A sequences capable of encoding the conserved receptor-binding d o m a i n (Nestor et al., 1985) of the E G F (1985) . The one-letter abbreviation code has been used. Residues invariant in all four EGF species are boxed. All six cysteine residues are invariant and the pattern of disulphide bridges linking these residues is indicated above the sequence data (Savage et al., 1973) . The conserved region indicated below (hEGF residues 36 to 42) comprises the third disulphide loop and has been implicated in receptor binding (Nestor et al., 1985) . It is a sequence of seven residues of which five are invariant. (b) Sequence of the degenerate oligonucleotide designed to select DNA sequences capable of encoding the conserved region indicated.
genome (Fig. 3) . Although the signal was weaker for MCV I the probe clearly hybridized to BamHI fragment B, ClaI fragment A and HindIII fragment C which overlap between 9 and 18 kb from the left-hand end of the genome. Thus the oligonucleotide hybridized to equivalent locations on both MCV genomes (Fig. 6) . Digests of MCV I or MCV II DNA were also hybridized with human EGF-and VGFspecific probes and filters were washed at low stringency (65 °C in 2 x SSC, 0.1 ~ SDS). Neither probe cross-hybridized with MCV DNA. Additionally, there was no cross-hybridization between MCV DNA and vaccinia DNA (data not shown).
DISCUSSION
Restriction endonuclease analysis reveals two subtypes of MCV. These subtypes induce phenotypically indistinguishable lesions but their DNA restriction maps obtained using three enzymes differ considerably. We have observed MCV II DNA in six of 29 cases examined. Darai et al. (1986) have also reported the existence of two subtypes, observing one instance of MCV II from 14 patients. The sizes of MCV I BamHI fragments that they report are in general agreement with our own, although these authors did not determine fragment molarities: the BamHI cleavage pattern of their MCV II isolate is similar to those reported here. Parr et al. (1977) described three cleavage patterns, of which two are similar to each other and to that of MCV I, while the third is similar to that of MCV II. There is no indication from these earlier data, or from our own, that MCV II is associated with any unusual clinical presentation.
The single MCV II isolate described by Darai eta/. (1986) was from the only genital lesion in their series. Parr et al. (1977) examined virus from a total of 10 lesions, two of which were genital; in both these cases the BamHI cleavage patterns of virus DNA correspond to MCV II, although they found this virus in other sites also. In contrast, we observed a total of six instances of MCV II, only one of which was of genital origin; MCV I was isolated from four other genital lesions. These observations suggest that, unlike infections with herpes simplex virus (HSV) strains, in which HSV-I is predominantly associated with oral lesions and HSV-2 with genital lesions (Chaney et aL, 1983) , there is no restriction of either MCV I or MCV II to any particular site. The sizes of the genomes of MCV I and MCV II are 185 kb and 195 kb respectively. We have demonstrated the presence of terminal cross-links and terminal inverted repetitions of 3.9 to 5.4 kb. Thus MCV DNA possesses some of the structural features of Orthopoxvirus DNA (Mackett & Archard, 19797 . However, it differs in its susceptibility to cleavage by endonuclease Sinai (recognition sequence CCCGGG) which generates more than 25 cuts in MCV DNA, in contrast to the few in Orthopoxvirus DNA (Mackett & Archard, 1979) . This result would be expected from the higher G + C content of MCV DNA (estimated as 60~o) compared to Orthopoxvirus DNA (Parr et al., 1977) .
Orthopoxvirus genomes possess an internal region that is highly conserved among different species (Mackett & Archard, 1979) . This contrasts with the genomes of MCV I and MCV II whose restriction maps show no such conservation. However, there is considerable sequence homology between the two subtypes, as fragments derived from one genome cross-hybridize with geographically equivalent fragments from the other. Thus the genomes of MCV I and MCV II are essentially colinear although there are two short discontinuities in which sequences present in one subtype have no counterpart in the other. This situation is analogous to the relationship between the genomes of HSV-1 and HSV-2 (McGeoch et al., 1987) .
Cleavage of DNA from different isolates of the same subtype revealed some heterogeneity. Most commonly, the size of terminal fragments was variable but loss of individual restriction sites has also been observed (data not shown). This terminal variation may imply a further similarity to Orthopoxvirus DNA, in the occurrence of variable numbers of tandem repetitions within the terminal inverted repeat (Wittek & Moss, 1980) , and was essentially the only variation seen in the genomes of 23 MCV I isolates. In contrast, MCV II isolates showed greater variability, particularly in the size 0f the BamHI/C fragment which maps outside the terminal repetition, and in the presence of several small fragments not mapped.
Our major interest in Molluscum contagiosum is the mechanism by which the virus induces epidermal cell proliferation. Having characterized the MCV genome structure by restriction mapping we wished to examine the possibility that cell proliferation results from expression of a virus-coded, EGF-like peptide. We prepared a degenerate oligonucleotide, designed to detect DNA sequences capable of encoding the conserved receptor-binding domain of EGF-related peptides. The conserved region is a seven amino acid oligopeptide with five invariant residues. The remaining two residues show no conservation and we chose to encode those present in the vaccinia virus growth factor (Venkatesan et al., 1982) . We reduced degeneracy by maximizing possible G to T 'wobble' pairing since a G-T base pair forms with little helix destabilization (Thein & Wallace, 1986) . The resulting 17-mer was 32-fold degenerate (Fig. 5) . Hybridizations with this probe identified restriction fragments, generated by three different enzymes, which overlap near the left terminus of the genomes of both subtypes of MCV at equivalent positions (Fig. 6) . The oligonucleotide also hybridized weakly to some other fragments but we attach no significance to these as hybridizations to equivalent fragments in other digests did not occur. In particular, hybridization to the unresolved BamHI/C and D fragments of MCV I DNA, each of which is 2-molar, was observed. We believe that this resulted from the large amount of virus DNA present at this position on the blots and does not represent an ambiguity. In contrast, the significant hybridizations were consistent in different digests and identify equivalent locations in both MCV genomes. The locus identified is between 9 and 18 kb from the left terminus of MCV I DNA and between 16 and 20 kb from the left terminus of MCV II DNA, similar to the position of the growth factor gene in vaccinia virus DNA (Venkatesan et al., 1982) .
These data indicate that MCV DNA has the potential to encode the conserved heptapeptide responsible for receptor binding by EGF-like peptides (Nestor et al., 1985) . We propose that MCV encodes a growth factor that is analogous to EGF and is responsible for cell proliferation and tumourigenesis. Further characterization of restriction fragments cloned from this region of the genome is proceeding.
We are grateful to Drs J. Cream, M. Muhlemann and S. Breathnach for supplying clinical material and to Drs J. Scott and A. Rice for human EGF-and VGF-specific probes respectively. We thank Miss L. Readings for typing the manuscript. C.D.P. is the recipient of a Cancer Research Campaign research studentship.
